source
- Q&A: Seaport CEO and CSO on learning from Karuna and the future of CNS researchSeaport Therapeutics began trading as a public company on Friday after executives rang the Nasdaq’s opening bell. Shares rose {$SPTX} more than 20%. With a team largely made up of Karuna Therapeuti…Endpoints · 2mo ago↗ source
- Samsung Biologics workers begin five-day strike over wage disputesAfter holding a rally in April, Samsung Biologics union workers on Friday started a five-day strike over wage negotiations. Around 95% of the company's union members voted on the strike, with the ...Endpoints · 2mo ago↗ source
- Acelyrin founder Shao-Lee Lin emerges at Cue, as it becomes latest to license from ChinaCue Biopharma announced a reboot Thursday afternoon, bringing in notable biotech executive Shao-Lee Lin as well as a new allergy asset developed in Taiwan and mainland China. The Boston-based biote…